![Hong-Tae Jeong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hong-Tae Jeong
Directeur Financier/CFO chez
CURIOX BIOSYSTEMS CO., LTD
Fortune : 3 M $ au 31/05/2026
Profil
Hong-Tae Jeong currently holds the positions of Chief Financial Officer, Director & Vice President at Curiox Biosystems Co., Ltd. since 2021, Director at Curiox Biosystems Pte Ltd., and Chief Financial Officer & Executive Vice President at Curiox BioSystems, Inc. The education history includes an undergraduate degree from Chung-Ang University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2026 | 57 050 ( 0,33% ) | 3 M $ | 31/05/2026 |
Postes actifs de Hong-Tae Jeong
| Sociétés | Poste | Début |
|---|---|---|
| CURIOX BIOSYSTEMS CO., LTD | Directeur Financier/CFO | 31/03/2021 |
Curiox Biosystems Pte Ltd.
 Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Directeur/Membre du Conseil | - |
Curiox Biosystems, Inc.
 Curiox Biosystems, Inc. Wholesale DistributorsDistribution Services Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Directeur Financier/CFO | - |
Formation de Hong-Tae Jeong
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Curiox Biosystems Pte Ltd.
Curiox Biosystems Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Develops innovative assay platforms | Commercial Services |
Chung-Ang University
 Chung-Ang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Curiox Biosystems, Inc.
Curiox Biosystems, Inc. Wholesale DistributorsDistribution Services Curiox Biosystems is a company that specializes in developing innovative technologies for life science research, diagnostics, and therapeutics discovery and development. The company was spun out of the Agency for Science, Technology, and Research (A*Star) and brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation. Curiox Biosystems' focus is on developing technologies that improve productivity and data quality by focusing on common assay steps where miniaturization and automation are currently underutilized. The aim is to simplify sample preparation while improving data quality and workflow, and to accelerate high-throughput flow and mass cytometry workflows with fully automated sample preparation. The Laminar Wash technology systems delivered by Curiox Biosystems are faster and easily automated, delivering higher quality data through better cell retention, improved preservation of cellular physiology and viability, exceptional study-to-study and operator-to-operator reproducibility. The company is based in Woburn, MA. The company was founded in 2008. The CEO is Namyong Kim. | Distribution Services |
Curiox Biosystems Co., Ltd.
 Curiox Biosystems Co., Ltd. Packaged SoftwareTechnology Services Develops bio equipment technology company | Technology Services |
